Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

HPV18 antibody

HPV-18 Reactivity: Human Papillomavirus 18 (HPV-18) IHC, StM Host: Mouse Monoclonal HPV18-1297 unconjugated
Catalog No. ABIN6937433
  • Target See all HPV18 (HPV-18) products
    HPV18 (HPV-18) (Human Papilloma Virus Type 18 (HPV-18))
    Reactivity
    • 1
    • 1
    • 1
    Human Papillomavirus 18 (HPV-18)
    Host
    • 3
    Mouse
    Clonality
    • 3
    Monoclonal
    Conjugate
    • 3
    This HPV18 antibody is un-conjugated
    Application
    • 2
    • 2
    • 1
    • 1
    Immunohistochemistry (IHC), Staining Methods (StM)
    Purification
    Purified by Protein A/G
    Immunogen
    HPV18 E6-β-galactosidase fusion protein
    Clone
    HPV18-1297
    Isotype
    IgG1 kappa
  • Application Notes

    Positive Control: HPV-18 infected cells. Cervical tissue.

    Known Application: Immunohistochemistry (Formalin-fixed) (0.5-1.0 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Restrictions
    For Research Use only
  • Buffer
    10 mM PBS without BSA and without Azide.
    Preservative
    Azide free
    Storage
    4 °C,-80 °C
    Storage Comment
    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months.
    Expiry Date
    24 months
  • Target
    HPV18 (HPV-18) (Human Papilloma Virus Type 18 (HPV-18))
    Alternative Name
    HPV-18 (Human Papilloma Virus 18) (HPV-18 Products)
    Target Type
    Viral Protein
    Background
    Human papilloma viruses (HPVs) can be classified as either high risk or low risk according to their association with cancer. HPV16 and HPV18 are the most common of the high risk group while HPV6 and HPV11 are among the low risk types. Approximately 90 % of cervical cancers contain HPV DNA of the high risk types. Mutational analysis has shown that the E6 and E7 genes of the high risk HPVs are necessary and sufficient for HPV transforming function. The specific interactions of the E6 and E7 proteins with p53 and pRB, respectively, correlate with HPV high and low risk classifications. The high risk HPV E7 proteins bind to pRB with a higher affinity than do the low risk HPV proteins, and only the high risk HPV E6 proteins form detectable complexes with p53 in vitro.
    Molecular Weight
    16kDa
You are here:
Support